Page last updated: 2024-08-16

technetium tc 99m sestamibi and Cystadenocarcinoma

technetium tc 99m sestamibi has been researched along with Cystadenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobkin, J; Fracasso, PM; Luker, GD; Piwnica-Worms, D1

Trials

1 trial(s) available for technetium tc 99m sestamibi and Cystadenocarcinoma

ArticleYear
Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclosporins; Cystadenocarcinoma; Drug Resistance, Multiple; Female; Humans; Kidney; Liver; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1997